Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Gentherm
THRM
$1.25B
| $22.4M | ﹤0.01% |
455,075
+15,598
| +4% | +$806K |
|
1602
Adient
ADNT
$1.65B
| $22.4M | ﹤0.01% |
908,059
+9,523
| +1% | +$270K |
|
1603
Roivant Sciences
ROIV
$24.5B
| $22.4M | ﹤0.01% |
2,120,785
+8,374
| +0.4% | +$91.8K |
|
|
FBMS
1604
DELISTED
The First Bancshares, Inc.
FBMS
| $22.4M | ﹤0.01% |
861,480
+13,918
| +2% | +$343K |
|
1605
NBT Bancorp
NBTB
$2.74B
| $22.3M | ﹤0.01% |
578,342
+25,637
| +5% | +$927K |
|
1606
Evertec
EVTC
$1.88B
| $22.2M | ﹤0.01% |
668,241
-38,193
| -5% | -$1.38M |
|
1607
Brady Corp
BRC
$4.44B
| $22.2M | ﹤0.01% |
336,132
+61,810
| +23% | +$3.87M |
|
1608
StoneX
SNEX
$9.26B
| $22.1M | ﹤0.01% |
991,845
+55,282
| +6% | +$1.18M |
|
1609
Ultragenyx Pharmaceutical
RARE
$2.45B
| $22.1M | ﹤0.01% |
537,616
+53,235
| +11% | +$2.27M |
|
|
HPP
1610
Hudson Pacific Properties
HPP
$747M
| $22M | ﹤0.01% |
654,092
+36,350
| +6% | +$1.37M |
|
1611
Alamo Group
ALG
$1.94B
| $22M | ﹤0.01% |
127,176
+4,639
| +4% | +$905K |
|
1612
PENN Entertainment
PENN
$2.75B
| $22M | ﹤0.01% |
1,135,379
+58,126
| +5% | +$987K |
|
1613
National Healthcare
NHC
$3.53B
| $22M | ﹤0.01% |
202,647
+5,995
| +3% | +$584K |
|
1614
Interparfums
IPAR
$3.99B
| $22M | ﹤0.01% |
189,202
+4,137
| +2% | +$502K |
|
1615
ACV Auctions
ACVA
$1.31B
| $21.9M | ﹤0.01% |
1,201,529
+141,622
| +13% | +$2.55M |
|
1616
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.03B
| $21.9M | ﹤0.01% |
715,141
-19,527
| -3% | -$586K |
|
|
DMC
1617
Del Monte Corp
DMC
$1.41B
| $21.9M | ﹤0.01% |
1,001,055
+74,672
| +8% | +$1.79M |
|
1618
Teladoc Health
TDOC
$1.22B
| $21.8M | ﹤0.01% |
2,230,824
+489,392
| +28% | +$5.97M |
|
1619
Joby Aviation
JOBY
$7.03B
| $21.8M | ﹤0.01% |
4,277,565
+378,451
| +10% | +$1.88M |
|
|
HIBB
1620
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $21.8M | ﹤0.01% |
250,016
-39,141
| -14% | -$3.24M |
|
1621
Penske Automotive Group
PAG
$14.3B
| $21.8M | ﹤0.01% |
146,198
+3,160
| +2% | +$480K |
|
1622
C3.ai
AI
$1.43B
| $21.8M | ﹤0.01% |
752,109
+21,228
| +3% | +$545K |
|
|
NARI
1623
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $21.8M | ﹤0.01% |
452,189
+39,970
| +10% | +$1.77M |
|
|
IBTX
1624
DELISTED
Independent Bank Group, Inc.
IBTX
| $21.8M | ﹤0.01% |
477,982
+24,347
| +5% | +$1.04M |
|
1625
Procept Biorobotics
PRCT
$1.06B
| $21.7M | ﹤0.01% |
355,900
+14,609
| +4% | +$869K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.